EXHIBIT 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Edesa Biotech, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
| Security Class Title |
| Fee Calculation Rule |
| Amount Registered(1) |
| Proposed Maximum Offering Price Per Share |
|
| Maximum Aggregate Offering Price |
| Fee Rate |
| Amount of Registration Fee |
| ||||
Equity |
| Common Shares, no par value per share |
| Rule 457(c) and Rule 457(h) |
| 1,380,000 | (3) | $ | 0.8988 | (2) |
| $ | 1,240,344 |
| $ | 0.0001102 |
| $ | 136.69 |
|
Total Offering Amounts |
|
|
|
|
|
| $ | 1,240,344 |
|
|
|
|
| 136.69 |
| |||||
Total Fee Offsets |
|
|
|
|
|
|
|
|
|
|
|
|
| - |
| |||||
Net Fee Due |
|
|
|
|
|
|
|
|
|
|
|
| $ | 136.69 |
| |||||
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended, this Registration Statement also covers such additional shares as may hereinafter be offered or issued to prevent dilution resulting from share splits, share dividends or similar transactions effected without the receipt of consideration. |
|
|
(2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) under the Securities Act of 1933, as amended, based on a per share price of $0.8988, the average of the high and low reported sales prices of the Registrant’s common shares on the NASDAQ Capital Market on May 22, 2023. |
|
|
(3) | Represents 1,380,000 shares reserved for issuance under the Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan. |
